These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 9229305
21. Reversible pulmonary hypertension, tricuspid regurgitation and right-sided heart failure associated with hyperthyroidism: case report and review of the literature. Lozano HF, Sharma CN. Cardiol Rev; 2004; 12(6):299-305. PubMed ID: 15476566 [Abstract] [Full Text] [Related]
22. [Impact of pulmonary hypertension on early hemodynamics after orthotopic heart transplantation]. Liu MZ, Wang JH, Du J, Huang J, Li LH. Zhonghua Yi Xue Za Zhi; 2007 Oct 09; 87(37):2618-22. PubMed ID: 18162149 [Abstract] [Full Text] [Related]
23. [Novel concepts in the pathobiology of pulmonary arterial hypertension]. Rosenkranz S. Dtsch Med Wochenschr; 2008 Oct 09; 133 Suppl 6():S167-9. PubMed ID: 18814087 [Abstract] [Full Text] [Related]
24. [In spite of normal or increased heart minute volume, myocardial dysfunction is common in septic shock]. Lind L, Mälstam J, Skoog G. Lakartidningen; 1993 Sep 01; 90(35):2848-52. PubMed ID: 8377558 [No Abstract] [Full Text] [Related]
25. [Decompensated pulmonary hypertension]. Desole S, Kähler CM. Dtsch Med Wochenschr; 2008 Oct 01; 133 Suppl 6():S215-8. PubMed ID: 18814101 [Abstract] [Full Text] [Related]
26. Fixed pulmonary hypertension and mechanical support: an unclear opportunity. Uriel N, Sims DB, Jorde UP. J Heart Lung Transplant; 2011 May 01; 30(5):600. PubMed ID: 21211996 [No Abstract] [Full Text] [Related]
27. [Pulmonary hemodynamics in obese patients: a brief review]. Denolin H. Bull Physiopathol Respir (Nancy); 1972 May 01; 8(5):1005-10. PubMed ID: 4266617 [No Abstract] [Full Text] [Related]
28. Post-transplant survival after lowering fixed pulmonary hypertension using left ventricular assist devices. Zimpfer D, Zrunek P, Sandner S, Schima H, Grimm M, Zuckermann A, Wolner E, Wieselthaler G. Eur J Cardiothorac Surg; 2007 Apr 01; 31(4):698-702. PubMed ID: 17289396 [Abstract] [Full Text] [Related]
29. First experiences with the stable prostacyclin analog iloprost in the evaluation of heart transplant candidates with increased pulmonary vascular resistance. Sablotzki A, Czeslick E, Gruenig E, Friedrich I, Schubert S, Börgermann J, Hentschel T. J Thorac Cardiovasc Surg; 2003 Apr 01; 125(4):960-2. PubMed ID: 12698166 [No Abstract] [Full Text] [Related]
30. [Pulmonary arterial hypertension in decompensated cardiopathies. Prognostic implications after heart transplantation. Anatomo-clinical correlates]. Chomette G, Auriol M, Koulibaly M, Cabrol C. Arch Anat Cytol Pathol; 1987 Apr 01; 35(5-6):262-7. PubMed ID: 3329894 [No Abstract] [Full Text] [Related]
31. Human, bovine and porcine systematic vascular input impedances are not equivalent: implications for device testing and xenotransplantation in heart failure. Koenig SC, Giridharan GA, Ewart DL, Schroeder MJ, Ionan C, Slaughter MS, Sobieski M, Pantalos GM, Dowling RD, Prabhu SD. J Heart Lung Transplant; 2008 Dec 01; 27(12):1340-7. PubMed ID: 19059115 [Abstract] [Full Text] [Related]
32. Pulmonary hypertension and congestive heart failure due to an intracerebral arteriovenous malformation. Colón J, Altieri PI, Martínez Toro JA. Bol Asoc Med P R; 1986 May 01; 78(5):199-200. PubMed ID: 3460603 [No Abstract] [Full Text] [Related]
34. Evaluation of pulmonary vascular response to inhaled iloprost in heart transplant candidates with pulmonary venous hypertension. Braun S, Schrötter H, Schmeisser A, Strasser RH. Int J Cardiol; 2007 Jan 31; 115(1):67-72. PubMed ID: 16797747 [Abstract] [Full Text] [Related]
35. The year in heart failure. Owens AT, Jessup M. J Am Coll Cardiol; 2011 Apr 12; 57(15):1573-83. PubMed ID: 21474036 [No Abstract] [Full Text] [Related]
36. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients. Ochiai Y, McCarthy PM, Smedira NG, Banbury MK, Navia JL, Feng J, Hsu AP, Yeager ML, Buda T, Hoercher KJ, Howard MW, Takagaki M, Doi K, Fukamachi K. Circulation; 2002 Sep 24; 106(12 Suppl 1):I198-202. PubMed ID: 12354733 [Abstract] [Full Text] [Related]
37. Left ventricular dysfunction with pulmonary hypertension: part 2: prognosis, noninvasive evaluation, treatment, and future research. Kalogeropoulos AP, Georgiopoulou VV, Borlaug BA, Gheorghiade M, Butler J. Circ Heart Fail; 2013 May 24; 6(3):584-93. PubMed ID: 23694772 [No Abstract] [Full Text] [Related]
38. [Role of the heart surgeon: indications for heart transplantation]. Feccia M, Musumeci F. G Ital Cardiol; 1999 Oct 24; 29(10):1204-7. PubMed ID: 10546135 [No Abstract] [Full Text] [Related]
39. Mild vs severe pulmonary hypertension before heart transplantation: different effects on posttransplantation pulmonary hypertension and mortality. Chang PP, Longenecker JC, Wang NY, Baughman KL, Conte JV, Hare JM, Kasper EK. J Heart Lung Transplant; 2005 Aug 24; 24(8):998-1007. PubMed ID: 16102433 [Abstract] [Full Text] [Related]
40. Nitric oxide versus prostaglandin E1 for reduction of pulmonary hypertension in heart transplant candidates. Radovancevic B, Vrtovec B, Thomas CD, Croitoru M, Myers TJ, Radovancevic R, Khan T, Massin EK, Frazier OH. J Heart Lung Transplant; 2005 Jun 24; 24(6):690-5. PubMed ID: 15949728 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]